Uploaded March 2025 | Updated September 2026, 3 days ago
For malignant brain cancers, such as glioblastoma, treatment options have not significantly improved. The current standard of care involves surgery followed by radiation or chemotherapy.
Dr. Kesari and his team are exploring a new approach. The PNI (Precision Immunotherapy in the Neoadjuvant setting) method uses targeted treatments based on the patient's tumor genetics before administering chemotherapy and radiation, when the immune system is stronger.
The goal is to prime the body to recognize and target the cancer as a foreign entity, enabling the body's own immune system to combat the disease before it is weakened by chemotherapy and radiation.
For malignant brain cancers, such as glioblastoma, treatment options have not significantly improved. The current standard of care involves surgery followed by radiation or chemotherapy.
Dr. Kesari and his team are exploring a new approach. The PNI (Precision Immunotherapy in the Neoadjuvant setting) method uses targeted treatments based on the patient's tumor genetics before administering chemotherapy and radiation, when the immune system is stronger.
The goal is to prime the body to recognize and target the cancer as a foreign entity, enabling the body's own immune system to combat the disease before it is weakened by chemotherapy and radiation.
